| Product Code: ETC9970771 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Molecular Imaging Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Molecular Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Molecular Imaging Market - Industry Life Cycle |
3.4 United States (US) Molecular Imaging Market - Porter's Five Forces |
3.5 United States (US) Molecular Imaging Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 United States (US) Molecular Imaging Market Revenues & Volume Share, By Device Type, 2021 & 2031F |
3.7 United States (US) Molecular Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Molecular Imaging Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 United States (US) Molecular Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Growing prevalence of chronic diseases such as cancer and cardiovascular disorders, increasing the demand for molecular imaging technologies. |
4.2.2 Technological advancements in imaging modalities, leading to higher accuracy and efficiency in diagnosis. |
4.2.3 Rising investments in healthcare infrastructure and research and development activities, supporting the adoption of molecular imaging techniques. |
4.3 Market Restraints |
4.3.1 High costs associated with molecular imaging equipment and procedures, limiting adoption rates. |
4.3.2 Regulatory challenges and stringent approval processes for new imaging agents and technologies. |
4.3.3 Limited availability of skilled professionals proficient in molecular imaging techniques. |
5 United States (US) Molecular Imaging Market Trends |
6 United States (US) Molecular Imaging Market, By Types |
6.1 United States (US) Molecular Imaging Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Molecular Imaging Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 United States (US) Molecular Imaging Market Revenues & Volume, By Magnetic Resonance Spectroscopy, 2021- 2031F |
6.1.4 United States (US) Molecular Imaging Market Revenues & Volume, By Optical Imaging, 2021- 2031F |
6.1.5 United States (US) Molecular Imaging Market Revenues & Volume, By Molecular Ultrasound Imaging, 2021- 2031F |
6.2 United States (US) Molecular Imaging Market, By Device Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Molecular Imaging Market Revenues & Volume, By Positron Emission Tomography (PET) Scanner, 2021- 2031F |
6.2.3 United States (US) Molecular Imaging Market Revenues & Volume, By Single Photon Emission Computed Tomography (SPECT) Scanner, 2021- 2031F |
6.2.4 United States (US) Molecular Imaging Market Revenues & Volume, By Gamma Camera, Nuclear Magnetic Resonance (NMR) Spectrometer, 2021- 2031F |
6.2.5 United States (US) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Molecular Imaging Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Molecular Imaging Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.3.3 United States (US) Molecular Imaging Market Revenues & Volume, By Neurology, 2021- 2031F |
6.3.4 United States (US) Molecular Imaging Market Revenues & Volume, By Respiratory, 2021- 2031F |
6.3.5 United States (US) Molecular Imaging Market Revenues & Volume, By Oncology, 2021- 2031F |
6.3.6 United States (US) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Molecular Imaging Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Molecular Imaging Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Molecular Imaging Market Revenues & Volume, By Diagnostic Imaging Centers, 2021- 2031F |
6.4.4 United States (US) Molecular Imaging Market Revenues & Volume, By Ambulatory Surgical Centers, 2021- 2031F |
6.4.5 United States (US) Molecular Imaging Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Molecular Imaging Market Import-Export Trade Statistics |
7.1 United States (US) Molecular Imaging Market Export to Major Countries |
7.2 United States (US) Molecular Imaging Market Imports from Major Countries |
8 United States (US) Molecular Imaging Market Key Performance Indicators |
8.1 Average scan time per patient, indicating efficiency and throughput of imaging procedures. |
8.2 Adoption rate of new molecular imaging technologies, reflecting market acceptance and innovation. |
8.3 Patient wait times for imaging appointments, showcasing accessibility and demand for imaging services. |
8.4 Rate of reimbursement for molecular imaging procedures, influencing affordability and utilization rates. |
9 United States (US) Molecular Imaging Market - Opportunity Assessment |
9.1 United States (US) Molecular Imaging Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 United States (US) Molecular Imaging Market Opportunity Assessment, By Device Type, 2021 & 2031F |
9.3 United States (US) Molecular Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Molecular Imaging Market Opportunity Assessment, By End users, 2021 & 2031F |
10 United States (US) Molecular Imaging Market - Competitive Landscape |
10.1 United States (US) Molecular Imaging Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Molecular Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here